Condition

Clinical trials for Liver Fibrosis

Active public studies that list Liver Fibrosis as a condition.

8active studies

6recruiting now

18countries represented

528largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver FibrosisCondition

Survodutide, PlaceboTreatment

Argentina, Australia528 locations

Boehringer IngelheimSponsor

Updated 2026-08-21 · NCT06632444See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowNot applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Obesity, Liver DiseasesCondition

ESG + lifestyle modification, Lifestyle modificationTreatment

United States2 locations

Pichamol Jirapinyo, MD, MPHSponsor

Updated 2026-06-25 · NCT06138821See eligibility →

Recruiting nowNot applicable

Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme

Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver FibrosisCondition

Intervention not listedTreatment

Spain1 locations

Hospital General Universitario Gregorio MarañonSponsor

Updated 2026-06-22 · NCT07658755See eligibility →

Recruiting nowNot applicable

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis

NASH, NAFLDCondition

Very-low-calorie ketogenic diet (VLCKD) with meal replacements, Mediterranean low-calorie diet (LCD)Treatment

Italy1 locations

University of BolognaSponsor

Updated 2024-03-15 · NCT06308757See eligibility →

Recruiting nowNot applicable

Biomarkers in the Diagnosis and Prognosis of NAFLD

NAFLD, ObesityCondition

Plasma Test, Plasma testTreatment

Italy1 locations

University of TriesteSponsor

Updated 2023-10-24 · NCT06098417See eligibility →

Opening soonNot applicable

Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients

Hyperuricemia, NAFLD (Nonalcoholic Fatty Liver Disease)Condition

*Lab Methods:* 1- Serum Uric Acid levels 2-Liver Function Tests 3- Lipid Profile . 4- Haemoglobin A1c level . 5- Serum glucose level ., *Imaging Studies:* 1- Ultrasound 2 - FibroScanTreatment

Locations pending0 locations

Assiut UniversitySponsor

Updated 2025-09-15 · NCT07168551See eligibility →

Invitation onlyPhase 4

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Diabetes Mellitus, Type 2, Liver FibrosisCondition

early time restricted Mediterranean diet, MysimbaTreatment

Netherlands1 locations

Carmen DietvorstSponsor

Updated 2026-04-21 · NCT06845345See eligibility →

Related conditions

Obesity1,102 Obesity & Overweight220 Overweight205 Overweight and Obesity130 Type 2 Diabetes108 Hypertension107

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.